课题基金 / 基金详情

Formulation studies on neuropeptides for type-2 diabetes treatment

Formulation studies on neuropeptides for type-2 diabetes treatment
神经肽治疗2型糖尿病的制剂研究
批准号:
22790043
负责人:
ONOUE Satomi
金额:
$2.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

ONOUE Satomi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The present study aimed to develop new therapeutic agent to treat type 2 diabetes with a focus on glucagon-secretin family neuropeptides. Biochemical studies and structure-activity relationship studies were undertaken to provide new promising derivatives of neuropeptides. To improve therapeutic compliance for neuropeptides, sustained-release dry powder formulation system was also established with use of biodegradable polymer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Inhalable Sustained-Release Formulation of Glucagon.
胰高血糖素可吸入缓释制剂的开发。
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Satomi Onoue, Kazuki Kuriyama, Atsushi Uchida, Takahiro Mizumoto, Shizuo Yamada]
通讯作者: Shizuo Yamada
DOI: 10.1016/j.ejpb.2010.11.005
发表时间: 2011-01-01
期刊: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
影响因子: 4.9
作者: [Kawabata, Yohei, Aoki, Yosuke, Yamada, Shizuo]
通讯作者: Yamada, Shizuo
Phrmacokinetics and pharmacodynamics of glucagon-loaded PLGA nanospheres for inhalation therapy.
用于吸入治疗的负载胰高血糖素的 PLGA 纳米球的药物动力学和药效学。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [栗山和樹, 尾上誠良, ほか]
通讯作者: ほか
Neurotrophic activities of newly developed pituitary adenylate cyclase activating polypeptide derivatives in central and peripheral nervous systems.
新开发的垂体腺苷酸环化酶激活多肽衍生物在中枢和周围神经系统中的神经营养活性。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [上野崇宏, Bahaa G. Youssif, 河野樹, 岡部泰之, 奥田健介, 門之園哲哉, 近藤科江, 永澤秀子, Satomi Onoue]
通讯作者: Satomi Onoue
23
    Development of bioactive peptide derivative and dry powder inhalation system for treatment of COPD
    • 批准号:
      20790103
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2008
    • 负责人:
      ONOUE Satomi
    • 依托单位:
    海外基金